Clinical Trials on mCRPC
Total 113 results
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)France
-
Pharmicell Co., Ltd.TerminatedCastration Resistant Prostate Cancer, CRPCKorea, Republic of
-
BIND TherapeuticsCompleted
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Blue Earth Therapeutics LtdPSI CRORecruitingUrogenital Neoplasms | Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCUnited States, Netherlands
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Translational Research Center for Medical Innovation...CompletedCastration Resistant Prostate Cancer (CRPC)
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Prostate Neoplasms | Castration Resistant Prostate Cancer (CRPC)Japan
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | AML | SCLC | Ovarian Carcinoma | Malignant Tumor | ESCC | CRPC | MFChina
-
Hansoh BioMedical R&D CompanyRecruitingMetastasis Castration Resistant Prostate Cancer(mCRPC)China
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Shanghai JMT-Bio Inc.Not yet recruitingMetastatic Colorectal Cancer (mCRC)
-
Sun Yat-sen UniversityHutchmed; BeiGeneNot yet recruitingMetastatic Colorectal Cancer | mCRCChina
-
Shanghai Henlius BiotechActive, not recruitingMetastatic Colorectal Cancer | mCRCChina
-
Bristol-Myers SquibbCompletedMetastatic Colorectal Cancer (mCRC)United States
-
ImmunityBio, Inc.Active, not recruiting
-
mAbxience Research S.L.Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDACompletedMetastatic Colorectal Cancer (mCRC)Argentina, Brazil, India, Spain, Ukraine
-
Sidney Kimmel Comprehensive Cancer Center at Johns...WithdrawnProstate Cancer | Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)United States
-
Bellicum PharmaceuticalsM.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaboratorsCompletedCastrate Resistant Prostate Cancer (CRPC)United States
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Peking UniversityZhejiang University; Liaoning Tumor Hospital & InstituteActive, not recruiting
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States
-
Tiltan Pharma Ltd.UnknownMetastatic Castration Resistant Prostate Cancer (CRPC)Israel
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Relative Bioavailability | Castration Resistant Prostate Cancer (CRPC) | MDV3100Germany
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingMetastatic Colorectal Cancer (mCRC)France
-
Shanghai Henlius BiotechActive, not recruitingMetastatic Colorectal Cancer (mCRC)China
-
Terumo Europe N.V.Universitaire Ziekenhuizen KU Leuven; Federation Francophone de Cancerologie...Completed
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedCastration Resistant Prostate Cancer (CRPC) | Pharmacokinetics of MDV3100South Africa
-
Duke UniversityCompletedMetastatic Renal Cell Carcinoma | Metastatic Urothelial Carcinoma | Metastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Tianjin Medical University Cancer Institute and...RecruitingSintilimab, Cetuximab, Regorafenib,Combine,mCRCChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingMetastatic Colorectal Cancer (mCRC)China
-
BayerActive, not recruitingMetastatic Colorectal Cancer (mCRC)United States
-
Bristol-Myers SquibbCompletedMetastatic Colorectal Cancer (MCRC)United States, Italy, Korea, Republic of, Spain, Sweden, Argentina, Denmark
-
Holy Stone Healthcare Co., LtdTemporarily not availableAdvanced or Metastatic Colorectal Cancer (mCRC)
-
Lipomedix Pharmaceuticals Inc.CompletedCancer | Solid Tumor | Metastatic Colorectal Cancer (mCRC)Israel
-
Effector TherapeuticsTerminatedCastrate-resistant Prostate Cancer (CRPC)United States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingMetastatic Castrate-resistant Prostate (CRPC) CancerFrance
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Holy Stone Healthcare Co., LtdCompletedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Colorectal Cancer (mCRC)United States
-
Pengyuan LiuRecruitingMetastatic Castration-resistant Prostate Cancer (CRPC)China
-
Lorenzo LiviUnknownRate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutatedChina
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Merck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States